Why See an Orthopedic Oncologist for TGCT Surgery?

Yes, whether you need to travel to see an orthopedic oncologist (a surgeon specializing in bone and soft tissue tumors) depends heavily on the type and extent of your tenosynovial giant cell tumor (TGCT). Many simple, localized TGCTs (a single, well-contained tumor nodule) can be successfully removed by a general orthopedic surgeon or sports medicine specialist who has experience with synovial tumors. However, for diffuse TGCT (a subtype that spreads extensively throughout the joint lining), recurrent tumors, or tumors located near critical nerves and blood vessels, seeking care at a specialized orthopedic oncology or sarcoma center is often highly recommended.

The Rarity of TGCT

TGCT is an uncommon, non-cancerous (benign) but locally aggressive tumor. While it does not spread to distant organs, it can cause significant joint damage if not managed properly. Research estimates that diffuse TGCT occurs in only about 4 to 8 out of every one million people per year ^[1][2].

Because of this rarity, a general orthopedic surgeon may see very few complex cases in their practice. Orthopedic oncologists at referral centers dedicate their practices to managing rare bone and soft tissue tumors ^[3]. They manage a higher volume of these cases, which helps them recognize the nuances of the disease and decide when aggressive surgery is necessary and when observation might be safer ^[4].

Balancing Tumor Removal and Joint Preservation

The central challenge in treating diffuse TGCT is balancing the need to remove the tumor with the need to protect the joint’s function. The surgical goal is usually a gross-total excision, meaning the removal of all visible tumor. This can be technically demanding because diffuse TGCT can extend throughout the joint and grow close to cartilage, ligaments, nerves, and blood vessels ^[5].

An orthopedic oncologist or experienced joint tumor specialist uses advanced MRI mapping to plan the procedure ^[5]. During surgery, they must carefully identify and protect these critical structures while removing the diseased tissue ^[5]. In some cases, the surgeon may even intentionally leave a small amount of tumor behind if removing it would cause permanent nerve damage or destroy the joint’s function.

The Risks of Residual Disease

If a substantial amount of tumor is left behind, the disease is more likely to continue growing and causing symptoms. One study looking specifically at open surgery for diffuse TGCT found that when surgeons intentionally left visible tumor behind, 73% of patients had disease progression on future MRIs, compared to 44% when the surgeon believed the tumor was completely removed ^[6]. Furthermore, when the first post-operative MRI showed visible residual tumor, 59% of those patients saw their disease progress, compared to only 7% of patients whose scans showed no visible disease ^[6].

While a recurrence does not automatically mean another surgery is required, repeated tumor growth and multiple revision operations can cause progressive damage to the joint cartilage ^[7][8]. Over time, this may lead to bone erosions and early osteoarthritis, which could eventually require a joint replacement in severe cases.

Multidisciplinary Care

For complex, diffuse, or recurrent TGCT, major treatment guidelines emphasize the importance of a multidisciplinary tumor board—a team of experts reviewing your case together ^[9][10]. This team typically includes:

• Musculoskeletal radiologists who review your MRIs to assess exactly where the tumor is located.
• Pathologists who confirm the exact diagnosis under a microscope.
• Medical oncologists who evaluate whether you are a candidate for systemic, targeted drug therapies. These medications are generally considered for symptomatic, diffuse TGCT when surgery would cause excessive joint damage or when the tumor is too extensive to be safely removed ^[10].

A second opinion from a specialist center is often a collaborative step rather than a permanent transfer of care. Getting input from a team that routinely handles complex TGCT can give you confidence that your treatment plan is tailored to your specific tumor, protecting your joint health for the long term.